ProfileGDS4718 / 1554606_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 13% 11% 14% 7% 11% 10% 13% 11% 10% 5% 3% 10% 11% 16% 20% 17% 12% 11% 6% 9% 10% 7% 13% 9% 12% 7% 3% 8% 6% 8% 7% 14% 6% 8% 9% 8% 10% 9% 9% 13% 5% 6% 9% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8103710
GSM549102patient 115, normal, homogenized [OPG study]3.9161413
GSM549104patient 119, normal, homogenized [OPG study]3.7782611
GSM549108patient 138, normal, homogenized [OPG study]3.9591914
GSM549119patient 077, normal, homogenized [OPG study]3.649217
GSM549133patient 032, cancer, homogenized [OPG study]3.7694111
GSM549139patient 042, cancer, homogenized [OPG study]3.7565210
GSM549099patient 107, normal, homogenized [OPG study]3.8812813
GSM549109patient 139, normal, homogenized [OPG study]3.8503111
GSM549110patient 046, normal, homogenized [OPG study]3.7866410
GSM549114patient 063, normal, homogenized [OPG study]3.570565
GSM549122patient 082, normal, homogenized [OPG study]3.475453
GSM549134patient 033, cancer, homogenized [OPG study]3.7914610
GSM549136patient 036, cancer, homogenized [OPG study]3.7589111
GSM549140patient 044, cancer, homogenized [OPG study]3.9583216
GSM549111patient 047, normal, homogenized [OPG study]4.1112720
GSM549113patient 057, normal, homogenized [OPG study]3.974917
GSM549132patient 031, cancer, homogenized [OPG study]3.8356712
GSM549137patient 038, cancer, homogenized [OPG study]3.796111
GSM549142patient 047, cancer, homogenized [OPG study]3.653496
GSM549100patient 110, normal, homogenized [OPG study]3.736289
GSM549107patient 135, normal, homogenized [OPG study]3.7518910
GSM549115patient 068, normal, homogenized [OPG study]3.652717
GSM549116patient 072, normal, homogenized [OPG study]3.8649313
GSM549120patient 078, normal, homogenized [OPG study]3.729979
GSM549131patient 030, cancer, homogenized [OPG study]3.8229912
GSM549118patient 074, normal, homogenized [OPG study]3.675197
GSM549129patient 027, cancer, homogenized [OPG study]3.503583
GSM549123patient 088, normal, homogenized [OPG study]3.701858
GSM549124patient 006, cancer, homogenized [OPG study]3.63286
GSM549126patient 015, cancer, homogenized [OPG study]3.69378
GSM549128patient 025, cancer, homogenized [OPG study]3.635417
GSM549103patient 117, normal, homogenized [OPG study]3.9636414
GSM549117patient 073, normal, homogenized [OPG study]3.634496
GSM549138patient 041, cancer, homogenized [OPG study]3.691438
GSM549141patient 045, cancer, homogenized [OPG study]3.67899
GSM549130patient 028, cancer, homogenized [OPG study]3.691968
GSM549101patient 111, normal, homogenized [OPG study]3.7742610
GSM549105patient 128, normal, homogenized [OPG study]3.748899
GSM549106patient 134, normal, homogenized [OPG study]3.719449
GSM549112patient 048, normal, homogenized [OPG study]3.8826913
GSM549125patient 011, cancer, homogenized [OPG study]3.555715
GSM549127patient 024, cancer, homogenized [OPG study]3.591126
GSM549135patient 035, cancer, homogenized [OPG study]3.68449